SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/1A034A26830AEE4C2C1687D0B73B04E55A8FF0C16AD6AC36003C1500B9113505F7072E96D2879443BC532E4DD2372B23>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/1A034A26830AEE4C2C1687D0B73B04E55A8FF0C16AD6AC36003C1500B9113505F7072E96D2879443BC532E4DD2372B23
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1A034A26830AEE4C2C1687D0B73B04E55A8FF0C16AD6AC36003C1500B9113505F7072E96D2879443BC532E4DD2372B23
http://www.w3.org/2000/01/rdf-schema#comment
"our results indicate that Elovl6 enhances oncogenic activity in liver cancer and is associated with poor prognosis in patients with HCC. Elovl6 may be a therapeutic target for HCC"
xsd:string
http://purl.uniprot.org/uniprot/#_6FFDBFB274594EA7D59A10BD9F538DAA3D95B7F0650034214078730F09E3492E6E59033C0670CE70B490CB1F564B5440
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/1A034A26830AEE4C2C1687D0B73B04E55A8FF0C16AD6AC36003C1500B9113505F7072E96D2879443BC532E4DD2372B23
http://purl.uniprot.org/uniprot/Q9H5J4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1A034A26830AEE4C2C1687D0B73B04E55A8FF0C16AD6AC36003C1500B9113505F7072E96D2879443BC532E4DD2372B23
http://purl.uniprot.org/uniprot/#_Q9H5J4-mappedCitation-29700319
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1A034A26830AEE4C2C1687D0B73B04E55A8FF0C16AD6AC36003C1500B9113505F7072E96D2879443BC532E4DD2372B23